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Graubünden – heavily dependent on sport-oriented tourism
– was one of the first Swiss cantons to adopt a workplace
smoking ban also including the hospitality business. In this
issue Bonetti et al. [1] confirm what they already observed
one year after the ban [2]: compared to the two years prior
to the ban, hospitalisations due to acute myocardial infarc-
tion (AMI) were 21% lower in the following two years (or
22% in the first year after the ban [2]).
Can this reduction plausibly be considered a consequence
of the smoking ban? The combustion of tobacco – exactly
as the combustion of other biomasses – is associated with
hundreds of toxic pollutants including large amounts of
particulate matter (PM). Combustion-related PM have
wide-ranging non-specific health effects [3]. Half a century
ago, the lack of specificity of those effects was the subject
of prolonged debate [4]. In the meantime these effects
have become fully explicable by the prevailing biological
paradigm that many chronic diseases share common patho-
logical pathways [5]. The strong oxidative capacity of PM,
the ability to induce local and systemic inflammation,
myocardial hypoxaemia, clotting of the blood, and modula-
tions in heart rate are just a few mechanisms which explain
why even myocardial infarction rates correlate with PM ex-
posure [6]. Best described is the dose-response curve for
Figure 1
Age-standardised mortality rate (per 100'000 inhabitants) for
myocardial infarction in the Cantons of Lucerne (triangles; dashed
line) and Graubünden (squares; solid lines), 1995–2008, for men
and women. Age standard: WHO world population. Mortality data:
from death statistics of the Swiss Federal Statistical Office (FSO).
Standardisation and graph: by Verena Jürgens, Swiss TPH Basel.
PM and mortality: the logarithm of the number of inhaled
particles is linearly associated with mortality all across the
range from low to moderate exposures to ambient PM or
passive smoking, to the usually higher indoor exposures in
households with biomass combustion, up to the extreme
PM doses active smokers opt for [7–8].
But can the impact of a smoking ban be that large – 21%?
Richiardi et al. derived all the necessary information from
the best available scientific literature to predict the impact
of smoking bans [9]. They reported a fall of 5–15%. A ma-
jor source of variation in these estimates related to the time
people are assumed to spend in smoky environments. The
"average model" used 1 hr/day. This is close to the mean
daily duration (1 hr 08 min) of secondhand smoking ex-
posure out-of-home reported on any day by 48% of non-
smokers in the Swiss city of Basel at times of no smoking
bans [10]. Thus, the 21% fall observed in Graubünden
seems to be substantially higher than expected. However,
a systematic review of 11 observational studies concluded
that smoking bans reduced AMI by 8–25% – an estimate
more supportive of the Alpine results [11].
Should we believe risk prediction models or pre-/post-com-
parisons of AMI frequencies? Comparisons of aggregated
crude data are prone to a broad range of biases that could
result in over- or underestimations of the true (unknown)
attributable impact. In fact, in epidemiological science such
“ecological studies” have a bad reputation similar to “case
reports” in clinical research. The two-year follow-up made
efforts to address some of the inherent limitations of the
previous one-year assessment. Most importantly, the up-
date compares results with the Canton of Lucerne. During
the study period Lucerne had no smoking ban and AMI
hospitalisations as reported to the Swiss AMI registry
(AMIS [12]) increased some 20% per year. The population
of Lucerne increased by 4.7% from 2006 to 2009, while
Graubünden’s grew 2.1% over the same period, so popula-
tion changes cannot fully account for differences between
the cantons’ AMI frequency. Trends in age-adjusted mor-
tality rates due to AMI were similar in the two cantons (fig.
1), showing a steady decrease from 1995 to 2001, partic-
ularly in men, with no strong patterns thereafter (fig. 1).
This raises the question whether the Lucerne trend as ob-
served in AMIS could be due in part to improved reporting
compliance in the first years after joining the (voluntary)
registry.
Swiss Medical Weekly · PDF of the online version · www.smw.ch Page 1 of 3
Trends in lipid-lowering treatment were very similar in
both cantons, with no evidence of a sudden increase or
fall that would coincide with the ban. There was neither a
trend nor a sudden change in ambient air pollutants. Nor,
however, was there an association between the monthly
mean ambient pollution and the monthly frequency of
AMI. As this is inconsistent with established evidence [6],
does it indicate that the study is flawed altogether? Not ex-
actly: with fewer than one AMI admission per day, and
with very minor fluctuations in the monthly mean levels of
PM10, it is not possible by the chosen analytic approach
to confirm the well-known association between air pollu-
tion and AMI in this data set. The impact of the (low) air
pollution in the Alps could instead be estimated from other
studies: for example, the recently published comparison of
triggers of AMI [13] leads to a crude rule-of-thumb that a
10 µg/m3 reduction in PM10 would result in a 2% reduc-
tion in AMI. This is far less than the fall observed after the
smoking ban. However, a sustained 10 µg/m3 reduction in
ambient PM would also reduce the development of chron-
ic pathologies [14]; thus, the long-term benefit of a “ban
on ambient air pollution” would be substantially larger than
expected in the first year [15].
Does a smoking ban only prevent acute cardiovascular
events or does it abate chronic pathologies such as athero-
sclerosis as well? The latter benefits would not be seen im-
mediately, whereas acute effects would be expected from
the first day of the regulation. Given the short time spent
in smoky air [10] I would see the ban first and foremost as
a strategy to remove an AMI trigger among non-smokers.
The results of the study (fig. 2 in [1]) are in line with this
thought as the fall was observed almost entirely among
those with known cardiovascular problems, and restricted
to non-smokers. Declines of AMI among smokers would
rather be related to long-term benefits of a decrease in the
amount of cigarettes smoked among smokers – a side ef-
fect of smoking bans observed elsewhere [11]. It would be
interesting to know whether, when and how far the ban af-
fected the smoking habits among smokers in Graubünden.
Combining all relevant co-factors with data from AMIS
– a visionary initiative for a voluntary registry taken in
a country with no tradition of morbidity registries
(http://www.amis-plus.ch/) – will provide opportunities to
rigorously investigate and quantify the acute and long-
term impact of the complex Swiss smoking ban landscape.
Novel approaches may be applied to control for temporal
and spatial trends. Such analyses may reveal to what extent
the observed 21% fall in AMI can be attributed to the vari-
ous consequences of the smoking ban.
However, the proposal for further research raises the ques-
tion whether such confirmatory studies should still be
done? And why should a scientific journal publish them,
even with an invited commentary? Smoking bans are a
highly effective, simple, and cheap structural prevention
with public health benefits far exceeding the prevention
of AMI [16]. However, structural prevention requires
policies, and thus decisions of legislatures, governments,
and the public – constituencies not necessarily motivated
by public health concerns but heavily pressured by various
lobbies spreading fictions as much as facts. As a result,
Swiss Federal regulations came not only late (May 2010)
but with the same loose ends and exceptions e.g., Spanish
policies kept alive for several years. Only recently did
Spain adopt the policy that works: a clear smoke-free
policy applied to all workplaces, including big and small
hospitality businesses [17–18]. In Switzerland there are
currently 15 cantons, including Graubünden, with better
policies than the Federal ones. A complicated policy carpet
of partial and complete bans is spreading across the (often
very small) 26 Swiss cantons. As some cantonal borders
pass through local communities, policies may even differ
as one crosses the street. But Swiss lawmakers are unlikely
to go for more consistent policies. Thus, >130'000 people
have signed an initiative asking for clear science-based
Federal policies. The ballot is pending
(http://www.rauchfrei-ja.ch/). In such a climate it is indeed
important to monitor pre/post changes despite inherent
weaknesses and the limited "novelty factor" of such con-
firmatory exercises. Confirming "the obvious" with less
than perfect local data is – unfortunately – often more im-
portant for local policymakers than some "rocket science"
done elsewhere. Studies from abroad have received far less
attention while reactions to data from the Alps were – and
will again – trigger committed discussions. Populist media
will of course weigh in with arguments originating from the
gut rather than the brain [19] and weaknesses of the follow-
up study will be highlighted with the (false) notion that
methodological flaws would always lead to false positive
findings. However, pseudoscientific uproars are unlikely to
turn public opinion round. According to surveys done in
14 countries and the many successes of canton-based ini-
tiatives in Switzerland, it is fairly clear that many societ-
ies have overcome the smoky fashions of the 20th century
and now defend the pleasure of smoke-free public envir-
onments [20–21]. A Swiss smoking ban was estimated to
reduce health costs by some 330 Mio. Swiss francs – cer-
tainly good news at times of constantly increasing health
care costs [22]. A solid majority that values the protec-
tion of health and wellbeing more than the ill-defined "free-
dom" or "right" to harm others will prevail.
No wonder! A fresh meal with a good glass of wine tastes
far better in a smoke-free environment – not only in
Graubünden!
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